No mutations of the Smad2 gene in human sporadic gastric carcinomas

Japanese Journal of Clinical Oncology

Volumn 29, Issue 1, 1999, Pages 3-7

  Shitara, Yoshinori ^a,b   Yokozaki, Hiroshi ^a   Yasui, Wataru ^a   Takenoshita, Seiichi ^b   Kuwano, Hiroyuki ^b   Nagamachi, Yukio ^b   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Gastric carcinoma; Mutation; Smad2

Indexed keywords

DNA BINDING PROTEIN; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; DNA SEQUENCE; GENETICS; HUMAN; MUTATION; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH TUMOR;

DNA-BINDING PROTEINS; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; STOMACH NEOPLASMS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032616124     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.1.3     Document Type: Article

References (40)

1. Franzén P, ten Dijke P, Ichijo H, Yamashita H, Schools P, Heldin C-H, et al. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 1993;75:681-92.
2. Yamashita H, ten Dijke P, Franzén P, Miyazono K, Heldin C-H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem 1994;269:20172-8.
3. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of TGFβ receptor. Nature 1994;370:341-7.
4. Macías-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 1996;87:1215-24.
5. Derynck R, Gelbart WM, Harland RM, Heldin C-H, Kem SE, Massagué J, et al. Nomenclature: Vertebrate mediators of TGF-β family signals. Cell 1996;87:173.
6. Sekelski JJ, Newfeld SJ, Raffery LA, Chartoff EH, Gelbart WM. Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 1995;139:1347-58.
7. Savage C, Das P, Finelli AL, Townsend SR, Sun CY, Baird SE, et al. Caenorhabditis elegans genes sma-2, sma-3 and sma-4 define a conserved family of transforming growth factor β pathway components. Proc Natl Acad Sci USA 1996;93:790-4.
8. Zhang Y, Feng X-H, Wu R-Y, Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 1996;383:168-72.
9. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, et al. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997;16:5353-62.
10. Souchelnytskyi S, Tamaki K, Engström U, Wernstedt C, ten Dijke P, Heldin C-H. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J Biol Chem 1997;272:28107-15.
11. Abdollah S, Macías-Silva M, Tsukazaki T, Hayashi H, Attisano, L Wrana JL. TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 1997;272:27678-85.
12. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 1996;383:832-6.
13. Chen X, Rubock MJ, Whitman M. A transcriptional partner for MAD proteins in TGF-β signalling. Nature 1996;383:691-6.
14. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, et al. MADR2 maps to 18q21 and encodes TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996;86:543-52.
15. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of chromosome 18q gene that is altered in colorectal cancers. Science 1990;247:49-56.
16. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
17. Miyake S, Nagai K, Yoshino K, Oto M, Endo M, Yuasa Y. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res 1994;54:3007-10.
18. Hahn SA, Hoque ATMS, Moskaluk CA, da Costa LT, Schutte M, Rozenblum E, et al. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 1996;56:490-4.
19. Barrett MT, Schutte M, Kern SE, Reid BJ. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res 1996;56:4351-3.
20. Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, et al. MAD-related genes in the human. Nature Genet 1996;13:347-9.
21. Uchida K, Nagatake M, Osada H, Yatabe Y, Kondo M, Mitsudomi T, et al. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res 1996;56:5583-5.
22. Takenoshita S, Mogi A, Nagashima M, Yang K, Yagi K, Hanyu A, et al. Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the transforming growth factor-β and activin signal transduction pathway. Genomics 1998;48:1-11.
23. Ochiai A, Yasui W, Tahara E. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn J Cancer Res 1985;76:1064-71.
24. Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 1991;51:381-6.
25. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, et al. Frequent loss of heterozygosity on chromosome 1q, 5q and 17p. Cancer Res 1991;51:2926-31.
26. Maesawa C, Tamura G, Nishizuka S, Iwaya T, Ogasawara S, Ishida K, et al. MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma. Jpn J Cancer Res 1997;88:340-3.
27. Kong X-T, Choi SH, Inoue A, Xu F, Chen T, Takita J, et al. Expression and mutational analysis of the DCC, DPC4 and MADR2/JV18-1 genes in neuroblastoma. Cancer Res 1997;57:3772-8.
28. Shitara Y, Yokozaki H, Yasui W, Takenoshita S, Nagamachi Y, Tahara E. Mutation of the transforming growth factor-β type II receptor gene is rare event in human sporadic gastric carcinomas. Int J Oncol 1998;12:1061-5.
29. Takenoshita S, Tani M, Mogi A, Nagashima M, Nagamachi Y, Bennet WP, et al. Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers. Carcinogenesis 1998;19:803-7.
30. Parsons R, Myeroff LL, Liu B, Willson JKV, Markowitz S, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-50.
31. Markowitz S, Wang J, Myeroff LL, Parsons R, Sun L, Lutterbaugh J, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
32. Myeroff LL, Parsons R, Kim S-J, Hedrick L, Cho KR, Orth K, et al. A Transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 1995;55:5545-7.
33. Vincent F, Nagashima M, Takenoshita S, Khan MA, Gemma A, Hagiwara K, et al. Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β. Oncogene 1997;15:117-22.
34. Garrigue-Antar L, Muñoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF. Reiss M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res 1995;55:3982-7.
35. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Sensibar JA, Kim J-H, et al. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res 1996;56:44-8.
36. Powell SM, Harper JC, Hamilton SR, Robinson CR, Cummings OW. Inactivation of Smad4 in gastric carcinomas. Cancer Res 1997;57:4221-4.
37. Arai T, Akiyama Y, Okabe S, Ando M, Endo M, Yuasa Y. Genetic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers. Cancer Lett 1998;122:157-63.
38. Hayashi H, Abdollah S, Qiu Y; Cai J, Xu Y-Y, Grinnell BW, et al. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 1997;89:1165-73.
39. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, et al. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 1997;389:631-5.
40. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, et al. Smad6 inhibits signalling by the TGF-β superfamily. Nature 1997;389:622-6.